Citadel Advisors
PCYC

Citadel Advisors’s PHARMACYCLICS INC PCYC Stock Holding History

Citadel Advisors’s Portfolio PCYC Stock Details PCYC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-2,152
Closed -$551K – 9445
2015
Q1 		$551K Sell
2,152
-15,920
-88% -$3.07M ﹤0.01% 4754
2014
Q4 		$2.21M Sell
18,072
-122,939
-87% -$15.7M ﹤0.01% 2801
2014
Q3 		$16.6M Buy
141,011
+42,837
+44% +$4.88M 0.02% 1023
2014
Q2 		$8.81M Sell
98,174
-29,319
-23% -$2.75M 0.01% 1372
2014
Q1 		$12.8M Buy
127,493
+44,550
+54% +$5.79M 0.02% 1116
2013
Q4 		$8.77M Buy
82,943
+29,409
+55% +$3.57M 0.01% 1295
2013
Q3 		$7.41M Buy
53,534
+48,230
+909% +$5.35M 0.01% 1292
2013
Q2 		$422K Buy
+5,304
New +$433K ﹤0.01% 3990

Other funds holding PCYC

Credit Agricole
Credit Agricole Montrouge Cedex, France $38.1B AUM

Citadel Advisors's PCYC Position: Q2 2015 in Review

Citadel Advisors sold out of PHARMACYCLICS INC (PCYC) in Q2 2015, closing a stake of 2,152 shares — an estimated $551K sold.

Citadel Advisors first reported a position in PCYC in Q2 2013 and held it in 8 quarters. The position peaked at $16.6M in Q3 2014. 1 fund tracked by Wall St. Rank holds PCYC as of Q2 2015.

  • Citadel Advisors reported no remaining PHARMACYCLICS INC position as of Q2 2015 after selling out during the quarter.
  • Citadel Advisors sold 2,152 PHARMACYCLICS INC shares in Q2 2015, an estimated $551K.
  • Citadel Advisors first reported a position in PHARMACYCLICS INC in Q2 2013 and held it in 8 quarters.
  • Citadel Advisors's PHARMACYCLICS INC position peaked at $16.6M in Q3 2014.
  • 1 fund tracked by Wall St. Rank held PHARMACYCLICS INC as of Q2 2015.

Based on Citadel Advisors's 13F filing for Q2 2015, filed 14 Aug 2015.